Old Mission Capital LLC Repligen Corp Transaction History

Old Mission Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $1.22 Million - $1.96 Million	-7,590 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$247.59 - $304.47 $1.28 Million - $1.58 Million	5,190 Added 216.25%	7,590 $2.01 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $467,448 - $778,104	2,400 New	2,400 $694,000
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $643,243 - $856,844	-3,878 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$180.37 - $226.26 $699,474 - $877,436	3,878 New	3,878 $754,000
Q3 2020 Nov 16, 2020	SELL	$122.51 - $158.27 $1.05 Million - $1.36 Million	-8,605 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $811,709 - $1.21 Million	8,605 New	8,605 $1.06 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.